继发性自身免疫性内耳病患者的人工耳蜗植入结局与患者报告获益
这项回顾性队列研究纳入7例继发性自身免疫性内耳病(AIED)相关重度感音神经性听力损失患者,比较其人工耳蜗植入(CI)结局与匹配对照组。术后12个月两组单音节识别均显著改善,AIED组增益54个百分点、对照组58个百分点(p<0.0001);AIED组噪声下句测试需更高信噪比,但SSQ12自评听力两组趋近。结论:尽管可能存在持续性内耳炎症,AIED患者仍从CI显著获益。
要点
- 继发性AIED相关重度感音神经性聋患者植入CI后12个月单音节识别显著改善。
- AIED组噪声下50%词语识别所需信噪比明显高于匹配对照组。
- SSQ12自评听力在AIED组与对照组均大幅提升且术后12个月趋于接近。
核心结论
- 继发性AIED患者在存在潜在持续性慢性内耳炎症的情况下仍可从人工耳蜗植入中获得显著获益。
- 尽管AIED组在单音节呈现和噪声下词语识别等经典听力学测试中表现较差,其自评听力与对照组近乎同样良好。
研究设计与样本
- 回顾性队列研究,纳入7例继发性AIED相关重度感音神经性听力损失并接受人工耳蜗植入的患者。
- 评估术前与术后纯音测听、安静与噪声下言语感知(德语Freiburg单音节与多音节测试、Oldenburg句子测试)及患者报告结局(SSQ12),并与匹配对照组比较。
主要发现
- 术后12个月AIED组与对照组在65 dBSPL下单音节识别均显著改善(p<0.0001),增益分别为54和58个百分点。
- AIED组在噪声下句子测试中达到50%词语识别所需的信号强度 substantially 高于对照组。
- 术后12个月SSQ12自评听力在AIED组为4.4 [2.4-6.5]、对照组为5.1 [4.5-5.8],两组均大幅改善且较术前组间差异趋于接近。
关键数值与推荐
- 术后12个月单音节识别(65 dBSPL)改善:AIED组增益54个百分点,对照组58个百分点,p<0.0001。
- 术后12个月SSQ12评分:AIED组4.4 [2.4-6.5],对照组5.1 [4.5-5.8]。
临床怎么用
- 对继发性AIED相关重度感音神经性聋患者,人工耳蜗植入可作为改善听力的有效干预。
- 应重视及时诊断、个体化术前影像评估和个体化康复,以优化AIED患者CI效果。
- 解读AIED患者CI效果时需结合自评听力结局,经典听力学测试可能低估其主观获益。
局限性
- 本研究为回顾性设计且AIED组样本量仅7例,结果解释需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate cochlear implant (CI) outcomes in patients with hearing loss related to secondary autoimmune inner ear disease (AIED) compared to a matched control cohort. PATIENTS AND METHODS: In this retrospective cohort study, we included seven patients with profound sensorineural hearing loss (SNHL) related to secondary AIED treated with a CI. Data on pre- and postoperative pure-tone audiometry, speech perception in quiet and noise (German Freiburg mono- and multisyllable test, Oldenburg sentence test), and patient-reported outcome measures (Speech, Spatial, and Qualities of Hearing Scale, SSQ12) were assessed and compared to a matched control cohort. RESULTS: Postoperative recognition of monosyllables (65 dBSPL) in AIED patients and controls showed significant improvement (p < 0.0001) after 12 months with gains of 54 and 58 percentage points, respectively. However, AIED patients required a substantially higher signal to achieve 50%-word recognition in sentence testing in noise compared to controls. Notably, subjective hearing abilities tested in the SSQ12 in both groups improved substantially, reaching 4.4 [2.4-6.5] in the AIED group and 5.1 [4.5-5.8] in controls at 12 months, showing a convergence of scores compared to the preoperative group difference. CONCLUSION: AIED patients substantially benefit from cochlear implantation despite potentially ongoing chronic inner-ear inflammation. In contrast to poorer performance in classical audiological test settings such as monosyllable presentation and word recognition in noise, self-perceived hearing was reported nearly as favorable as in the control cohort. Timely diagnosis, tailored preoperative imaging, and individualized rehabilitation are key to improved CI performance in AIED patients.
引用
- Hartmann M, Oestreicher D, Hüser MA, et al. Cochlear Implantation in Autoimmune Inner-Ear Disease: Outcome and Patient-Reported Benefit. Laryngoscope. 2026. PMID: 41947311. doi:10.1002/lary.70548
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。